StemCell Therapy

VERSUS Arthritis, the UKs leading charity for people with arthritis, has appointed Dr Neha Issar-Brown as its new Director of Research.

Neha joins from Fight for Sight where she was Director of Research, Policy and Innovation, supporting pioneering research to prevent sight loss. She also initiated the framework for the charitys first patient-centred research strategy.

In her new role, Neha will be responsible for developing Versus Arthritis own research strategy, aimed at making sure that research discoveries are rapidly translated into life-changing treatments for people with arthritis, along with ensuring that the level of investment in arthritis research reflects the prevalence of a condition that impacts one in six people in the UK.

Her previous roles include Head of Population Health and System Medicine at the UKRIs Medical Research Council (MRC).

Neha will be taking up her new position in February and said:

I am thrilled to be joining Versus Arthritis at this exciting time in the development of its research strategy.

I am particularly excited about working for an organisation that has such a strong track record in putting people with arthritis at the heart of its work, ensuring that no decision is made without the involvement of those who will be directly impacted.

Im looking forward to becoming part of an amazing team and to driving progress for millions of people with arthritis.

Ellen Miller, Deputy Chief Executive of Versus Arthritis, said:

Were delighted to welcome Neha to Versus Arthritis at such a significant time.

The COVID-19 pandemic and Brexit have put a huge strain on medical research charities, but with Nehas breadth of experience alongside our incredible partners and supporters, were in a very good position to build on and continue supporting world-leading research that will fundamentally change the lives of people with arthritis.

See the article here:
Versus Arthritis appoints new director of research - Charity Today News

This entry was posted on January 19, 2021 at 12:48 pm and is filed under Arthritis. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |